Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.00
Bid: 34.00
Ask: 36.00
Change: 4.00 (12.90%)
Spread: 2.00 (5.882%)
Open: 33.50
High: 35.00
Low: 33.50
Prev. Close: 31.00
SYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

3 Jul 2007 07:02

System C Healthcare plc03 July 2007 System C Healthcare PLC expands into private healthcare sector Acquisition of IQ Systems Services Ltd System C Healthcare PLC ("System C") (AIM:SYS), the provider of specialist ITproducts and services to the healthcare sector announces a significant strategicstep into the private healthcare market with the acquisition of IQ SystemsServices Ltd ("IQ") for a maximum consideration of £2.16m. IQ is a leading supplier of patient management and clinical software solutionsfor private treatment centres and hospitals. Its IQUtopia product is highlyregarded in the private healthcare marketplace and has been deployed at a numberof the most prestigious private sector treatment centres in the countryincluding Sussex Orthopaedic NHS Treatment Centre, Will Adams NHS TreatmentCentre (Gillingham), St Marys NHS Treatment Centre (Portsmouth), Midlands NHSTreatment Centre (Burton) and Eccleshill NHS Treatment Centre (Bradford) amongstothers. IQUtopia complements System C's MedWay Patient Administration andElectronic Patient Record (EPR) software, which is typically deployed intolarger NHS Acute Trusts. The acquisition of IQ accelerates System C's expansion into the privatehealthcare market as well as strengthening its product portfolio. IQ's customersinclude a number of major private healthcare providers including MercuryHealthcare (acquired by Care UK in April 2007), Centres of Clinical Excellence("CCE") and Nations Healthcare (acquired by CCE in June 2007). The consideration for the acquisition is £0.8m in cash on completion, with up toa further £1.36m payable in a mixture of cash and shares over the next 2 yearsdependent on the achievement of performance targets. The cash element of theconsideration is to be funded from the Group's existing resources. In the yearto 31 December 2006, IQ reported turnover of £0.9m, normalised PBT of £0.15mand, as at 31 December 2006, had Gross assets of £0.25m. The board expects theacquisition to be earnings enhancing from day one. (1) System C's Chief Executive, Ian Denley, commented: "We are delighted that IQ has chosen to become a fully integrated part of theSystem C business. We believe that the role of the private sector in most majorhealth economies will be become increasingly important over the medium term, andwith its significant customers and an established and well thought of product,the acquisition of IQ enables System C to expand directly into the privatehealthcare provider market. We will work closely with IQ to enhance IQUtopia, strengthen the professionalservices available to IQ customers, and further expand the strategicrelationship with their clients." John Wyatt Barton, Co-director of IQ, highlighted the product and servicessynergies between the companies: "Working with System C will open up many new opportunities for us. Theirprofessional services capability and their scale are just what our clients havebeen asking for and they have key products which complement IQUtopia. There is a tremendous cultural fit between the two companies and we look forwardto working in close collaboration to meet the exciting new opportunities ahead." ENDS For further information, please contact: System C Healthcare plc Dr Ian Denley, Chief Executive Markus Bolton, Founding Director Tel: 01622 691616 Maitland Emma Burdett/Richard Farnsworth Tel: 020 7379 5151 Collins Stewart Europe Ltd Chris Wells/Mark Connelly Tel: 020 7523 8350 Notes to editors: System C Healthcare plc (www.systemc.com), established in 1983, specialises inthe provision of information systems and solutions to the healthcare sector. Itsstaff have an average of 15 years' healthcare experience and can provide allaspects of systems design, development and deployment services. System C isfounded upon the belief that IT solutions, when effectively implemented, cansignificantly contribute towards improving patient care. System C is a specialist developer and supplier of Patient Administration andElectronic Patient Record Systems to the health service. The company's MedWayproduct is successfully installed at a number of NHS hospitals includingUniversity Hospitals Aintree, Swindon and Marlborough NHS Trust, TamesideHospitals NHS Trust and the Christie, one of the UK's leading cancer hospitals.System C has recently won a £7.5m contract to supply MedWay to the Isle of ManGovernment. System C has helped to install healthcare systems at over 130 NHS Trusts andoffers a wide range of services to Local Service Providers, the NHS andthird-party suppliers. These include programme/project/change management,design, build and test, implementation, training, data migration, interfacingand helpdesk/support services. Within the National Programme for IT (NPfIT),System C people have been involved in the majority of secondary care go-lives todate as well as many GP, community, Single Assessment Programme and child healthdeployments. -------------------------- (1) This statement should not be interpreted as a profit forecast and does notmean that the future earnings per share of System C, following completion of theacquisition of IQ, would necessarily match or exceed the historical earnings pershare of System C. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Feb 20199:30 amRNSDirector/PDMR Shareholding
22nd Feb 201910:17 amRNSResult of GM and Completion of Acquisition
11th Feb 20197:00 amRNSDirector's Share Purchase
6th Feb 201911:07 amRNSAcquisition of Certus IT Limited and Placing
20th Dec 20189:48 amRNSHolding(s) in Company
20th Dec 20189:47 amRNSHolding(s) in Company
27th Nov 20187:00 amRNSGrant of Options
26th Nov 20182:40 pmRNSDirector's Share Purchase
26th Nov 20187:00 amRNSHalf-year Report
1st Nov 20187:00 amRNSNotice of Results
21st Sep 201811:17 amRNSResult of AGM
11th Sep 201811:32 amRNSHolding(s) in Company
24th Jul 20181:30 pmRNSReplacement: Notice of AGM and Board Change
24th Jul 20187:00 amRNSNotice of AGM
16th Jul 20187:00 amRNSLTIP Grant
2nd Jul 201812:43 pmRNSReplacement Implementation of LTIP & initial grant
29th Jun 20187:00 amRNSImplementation of LTIP and initial grant
27th Jun 20187:01 amRNSAppointment of a Director and Board transition
27th Jun 20187:00 amRNSFinal Results
6th Jun 20187:00 amRNSNotice of Results
21st May 20189:14 amRNSHolding(s) in Company
21st May 20189:10 amRNSHolding(s) in Company
23rd Apr 20187:00 amRNSTrading Update and Notice of Results
3rd Apr 20187:00 amRNSBoard Changes and launch of new investor website
5th Mar 20187:00 amRNSContract Win
26th Jan 20182:19 pmRNSDirector's Share Purchase
8th Jan 20187:00 amRNSAppointment of Non-Executive Director to the Board
6th Dec 20177:00 amRNSHalf-year Report
7th Nov 20171:58 pmRNSHolding(s) in Company
7th Nov 20177:00 amRNSBoard Changes
6th Nov 20177:00 amRNSTrading Update
3rd Nov 20172:36 pmRNSHolding(s) in Company
2nd Nov 20177:00 amRNSNotice of Results
1st Nov 20177:00 amRNSAcquisition of Rockford IT
31st Oct 20177:00 amRNSAppointment of COO to the Board
23rd Oct 20177:00 amRNSDirectorate Change
20th Sep 201712:44 pmRNSHolding(s) in Company
25th Aug 20172:37 pmRNSResult of AGM
24th Aug 20177:00 amRNSDirector/PDMR Shareholding
23rd Aug 20172:27 pmRNSHolding(s) in Company
22nd Aug 20173:51 pmRNSDirector and PDMR share purchases
24th Jul 20177:00 amRNSDirector's share purchase
12th Jul 201710:30 amRNSAvailability of Annual Accounts & Notice of AGM
7th Jun 20177:00 amRNSFinal Results
2nd May 20174:08 pmRNSFurther Trading Update
6th Apr 20172:00 pmRNSGrant of Options and Director/PDMR Disclosure
6th Apr 20177:00 amRNSTrading Update, Board Appointment
16th Mar 20175:00 pmRNSHolding(s) in Company
7th Mar 20178:05 amRNSCorrection: Payment of Deferred Consideration
7th Mar 20177:00 amRNSDeferred Consideration and Issue of Equity re Q4Ex

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.